By using multiple independent breast cancer profiling studies, a MetaCOPA bioinformatics analysis has allowed prioritizing AGTR1 as a second ranked meta-outlier, immediately after HER2neu, which was identified as the most significant meta-outlier [137]. This evidence concerns the gene AGTR1 and breast cancer.